High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study

被引：0
|
作者：
Yue-E Liu
Qiang Lin
Fan-Jie Meng
Xue-Ji Chen
Xiao-Cang Ren
Bin Cao
Na Wang
Jie Zong
Yu Peng
Ya-Jun Ku
Yan Chen
机构：
[1] North China Petroleum Bureau General Hospital of Hebei Medical University,Department of Oncology
来源：
Radiation Oncology | / 8卷
关键词：
Non-small-cell lung cancer; Accelerated hypofractionated radiotherapy; Concurrent chemoradiotherapy; Three-dimensional conformal radiotherapy; Vinorelbine; Carboplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study
    Liu, Yue-E
    Lin, Qiang
    Meng, Fan-Jie
    Chen, Xue-Ji
    Ren, Xiao-Cang
    Cao, Bin
    Wang, Na
    Zong, Jie
    Peng, Yu
    Ku, Ya-Jun
    Chen, Yan
    RADIATION ONCOLOGY, 2013, 8
  • [2] Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial
    Lin, Qiang
    Liu, Yue-E
    Ren, Xiao-Cang
    Wang, Na
    Chen, Xue-Ji
    Wang, Dong-Ying
    Zong, Jie
    Peng, Yu
    Guo, Zhi-Jun
    Hu, Jing
    RADIATION ONCOLOGY, 2013, 8
  • [3] Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial
    Qiang Lin
    Yue-E Liu
    Xiao-Cang Ren
    Na Wang
    Xue-Ji Chen
    Dong-Ying Wang
    Jie Zong
    Yu Peng
    Zhi-Jun Guo
    Jing Hu
    Radiation Oncology, 8
  • [4] High-dose 3-dimensional conformal radiotherapy with concomitant vinorelbine plus carboplatin in patients with non-small cell lung cancer: A feasibility study
    Lin, Qiang
    Wang, Jun
    Liu, Yue'e
    Su, Huiling
    Wang, Na
    Huang, Yuehua
    Liu, Chao-Xing
    Zhang, Ping
    Zhao, Yannan
    Chen, Kun
    ONCOLOGY LETTERS, 2011, 2 (04) : 669 - 674
  • [5] Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
    Kepka, Lucyna
    Tyc-Szczepaniak, Dobromira
    Bujko, Krzysztof
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) : 853 - 861
  • [6] Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer
    Ishida, Koko
    Hirose, Takashi
    Yokouchi, Junichi
    Oki, Yasunari
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Ishida, Hiroo
    Shirai, Takao
    Nakashima, Masanao
    Yamaoka, Toshimitsu
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Kagami, Yoshikazu
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (03) : 405 - 410
  • [7] Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: A phase I/II study
    Glinski, Krzysztof
    Socha, Joanna
    Wasilewska-Tesluk, Ewa
    Komosinska, Katarzyna
    Kepka, Lucyna
    RADIOTHERAPY AND ONCOLOGY, 2020, 148 : 174 - 180
  • [8] Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy
    Thirion, P
    Holmberg, O
    Collins, CD
    O'Shea, C
    Moriarty, M
    Pomeroy, M
    O'Sullivan, C
    Buckney, S
    Armstrong, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 (02) : 163 - 166
  • [9] Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy
    Wei, Xiong
    Liu, H. Helen
    Tucker, Susan L.
    Liao, Zhongxing
    Hu, Chaosu
    Mohan, Radhe
    Cox, James D.
    Komaki, Ritsuko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 100 - 107
  • [10] Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer
    Landman, Yosef
    Jacobi, Oded
    Kurman, Noga
    Yariv, Orly
    Peretz, Idit
    Rotem, Ofer
    Dudnik, Elizabeth
    Zer, Alona
    Allen, Aaron M.
    ONCOIMMUNOLOGY, 2021, 10 (01):
12345